ZYDUS LIFESCIENCES
|
The Current P/E Ratio of ZYDUS LIFESCIENCES is 18.62.
| Share Price | ₹913.0 | Mar 06,2026 |
| Market Cap | ₹91,861.0 Cr | |
| Earnings-TTM | ₹4,933.9 Cr | TTM-Consolidated Results |
| Price/Earnings | 18.62x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ZYDUS LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹91,861.0 Cr] as on Mar 06,2026
(/) Earnings [ ₹4,933.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 18.62x ]
Thus, for ZYDUS LIFESCIENCES , the investors are currently willing to pay 18.62 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ZYDUS LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ZYDUS LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of ZYDUS LIFESCIENCES
PE Ratio Performance Analysis for ZYDUS LIFESCIENCES
- ZYDUS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 20.08x.
- ZYDUS LIFESCIENCES 's operated at median p/e ratio of 21.16x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ZYDUS LIFESCIENCES 's p/e ratio peaked in Mar2024 at 26.2x.
- ZYDUS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2022 of 7.96x.
How does ZYDUS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ZYDUS LIFESCIENCES | 4,933.90 | 18.62 | 91,861.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 39.23 | 431,628.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 67.76 | 167,975.0 |
| CIPLA LTD | 4,544.70 | 23.49 | 106,768.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 64.17 | 145,804.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.76 | 108,829.0 |
| MANKIND PHARMA LTD | 1,796.65 | 50.24 | 90,257.8 |
| LUPIN LTD | 4,669.18 | 22.95 | 107,152.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 20.36 | 71,531.5 |
| ABBOTT INDIA LTD | 1,524.13 | 38.12 | 58,106.6 |
| ALKEM LABORATORIES LTD | 2,424.46 | 27.32 | 66,239.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ZYDUS LIFESCIENCES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.62x |
| Max industry PE | 67.76x |
| Median industry PE | 27.32x |
| Average industry PE | 35.64x |
You may also like the below Video Courses